This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2g2i

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2g2i.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2g2i.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2g2i| PDB=2g2i | SCENE= }}
{{STRUCTURE_2g2i| PDB=2g2i | SCENE= }}
-
'''A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain'''
+
===A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain===
-
==Overview==
+
<!--
-
The improper activation of the Abl tyrosine kinase results in chronic myeloid leukemia (CML). The recognition of an inactive conformation of Abl, in which a catalytically important Asp-Phe-Gly (DFG) motif is flipped by approximately 180 degrees with respect to the active conformation, underlies the specificity of the cancer drug imatinib, which is used to treat CML. The DFG motif is not flipped in crystal structures of inactive forms of the closely related Src kinases, and imatinib does not inhibit c-Src. We present a structure of the kinase domain of Abl, determined in complex with an ATP-peptide conjugate, in which the protein adopts an inactive conformation that resembles closely that of the Src kinases. An interesting aspect of the Src-like inactive structure, suggested by molecular dynamics simulations and additional crystal structures, is the presence of features that might facilitate the flip of the DFG motif by providing room for the phenylalanine to move and by coordinating the aspartate side chain as it leaves the active site. One class of mutations in BCR-Abl that confers resistance to imatinib appears more likely to destabilize the inactive Src-like conformation than the active or imatinib-bound conformations. Our results suggest that interconversion between distinctly different inactive conformations is a characteristic feature of the Abl kinase domain.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16640460}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16640460 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16640460}}
==About this Structure==
==About this Structure==
Line 25: Line 29:
[[Category: Levinson, N M.]]
[[Category: Levinson, N M.]]
[[Category: Protein kinase]]
[[Category: Protein kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:37:07 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 05:42:04 2008''

Revision as of 02:42, 28 July 2008

Image:2g2i.png

Template:STRUCTURE 2g2i

A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain

Template:ABSTRACT PUBMED 16640460

About this Structure

2G2I is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

A Src-like inactive conformation in the abl tyrosine kinase domain., Levinson NM, Kuchment O, Shen K, Young MA, Koldobskiy M, Karplus M, Cole PA, Kuriyan J, PLoS Biol. 2006 May;4(5):e144. Epub 2006 May 2. PMID:16640460

Page seeded by OCA on Mon Jul 28 05:42:04 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2g2i"
Personal tools